Condition

Oligometastatic Prostate Cancer clinical trials and research

• 7Clinical trials
• 6Countries

Newest Oligometastatic Prostate Cancer clinical trials

All recruiting trials (7)

• Prostate Radiotherapy and Metastasis-Directed Therapy in Synchronous Oligometastatic Prostate Cancer

  This registry follows men with new, limited metastatic prostate cancer who receive targeted radiotherapy to the prostate and all visible metastases to see how they do over time in real-world care.

  Recruiting Affidea Nu-med Center of Oncological DIagnostics and Therapy · Zamość, Lublin Voivodeship · NCT07686016

• Comprehensive radiotherapy to all metastases plus primary prostate radiotherapy versus prostate-only radiotherapy for men with oligometastatic prostate cancer

  This tests whether adding radiation to all PSMA-PET-visible metastases along with standard systemic therapy helps men with newly diagnosed oligometastatic prostate cancer stay progression-free longer than treating the prostate alone.

  Recruiting Peking University First Hospital · Beijing, Beijing Municipality and 2 other locations · NCT07015138

• Maximal tumor eradication for patients with oligometastatic prostate cancer

  This study is testing a new combination treatment for men with oligometastatic prostate cancer to see if it can improve their survival and quality of life.

  Recruiting Phase 2/3 RenJi Hospital · Shanghai · NCT06972511

• Genomic biomarker-guided therapy for advanced prostate cancer

  This study is testing if personalized treatment based on genetic markers can help men with advanced prostate cancer before surgery.

  Recruiting Phase 2 The First Affiliated Hospital of Xiamen University · Xiamen, Fujian · NCT06387056

• Combining immune therapy and radiation for prostate cancer treatment

  This study is testing a new treatment that combines immune therapy drugs with targeted radiation to see if it helps men with a specific type of prostate cancer live longer and feel better.

  Recruiting Phase 2 Columbia University · New York, New York · NCT05915442

• Using Lu-PSMA with SABR for treating oligometastatic prostate cancer

  This study is testing whether adding a special targeted therapy called Lu-PSMA to radiation treatment can help people with a few spots of prostate cancer live longer without their cancer getting worse.

  Recruiting at 4 sites Phase 2 Peter MacCallum Cancer Centre, Australia · St Leonards, New South Wales and 3 other locations · NCT05560659

• Comparing different radiation therapies for treating oligometastatic prostate cancer

  This study is testing whether new types of radiation therapy can help men with oligometastatic prostate cancer feel better and live longer compared to standard treatment.

  Recruiting at 3 sites British Columbia Cancer Agency · Kelowna, British Columbia and 3 other locations · NCT04610372

Related topics

Quick answers

How many Oligometastatic Prostate Cancer clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 6 countries. The most sites are in China (3 trials), United States (1 trial), Australia (1 trial), Israel (1 trial), Poland (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 3, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →